Abstract
Autologous stem cell transplantation (ASCT) is standard therapy for mantle cell lymphoma (MCL) in remission after induction chemotherapy, with the best results for patients in complete remission (CR). We hypothesized that evaluation of minimal residual disease (MRD) before ASCT could further stratify outcomes for these patients. Patients with MCL who underwent ASCT in clinical CR between 1996 and 2011 with pretransplantation MRD testing were eligible. Presence of a clonal IgH rearrangement, t(11; 14) by PCR or positive flow cytometry from blood or bone marrow, was considered positive. An adjusted proportional hazards model for associations with progression-free (PFS) and overall survival (OS) was performed. Of 75 MCL patients in CR, 8 (11%) were MRD positive. MRD positivity was associated with shorter OS and PFS. The median OS for MRD-negative patients was not reached, with 82% survival at 5 years, whereas for the MRD-positive patients, median OS was 3.01 years (hazard ratio [HR], 4.04; P = .009), with a median follow-up of 5.1 years. The median PFS for MRD-negative patients was not reached with 75% PFS at 5 years, whereas for MRD-positive patients, it was 2.38 years (HR, 3.69; P = .002). MRD positivity is independently associa...Continue Reading
References
Jul 29, 2000·Leukemia·B SolaX Troussard
Dec 13, 2003·Leukemia·J J M van DongenE A Macintyre
Dec 14, 2004·Blood·Martin DreylingWolfgang Hiddemann
Dec 8, 2005·Blood·Christiane PottMichael Kneba
Oct 20, 2006·American Journal of Clinical Pathology·Jonathan R FrommBrent L Wood
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Oct 27, 2007·Blood·Eva HosterUNKNOWN European Mantle Cell Lymphoma Network
Jul 11, 2008·Cancer·Yuhong ZhouMichael Wang
Jul 16, 2008·Blood·Christian H GeislerUNKNOWN Nordic Lymphoma Group
Jul 25, 2008·Clinical Lymphoma & Myeloma·Saar GillJohn F Seymour
Feb 21, 2009·American Journal of Clinical Pathology·Jonathan R FrommBrent L Wood
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lloyd E DamonGeorge P Canellos
Dec 25, 2009·Blood·Christiane PottMartin Dreyling
Dec 25, 2009·Blood·Christian H GeislerUNKNOWN Nordic Lymphoma Group
Apr 30, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Caroline Bodet-MilinSteven Le Gouill
Jul 7, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lihua E BuddeAjay K Gopal
Nov 22, 2011·Haematologica·Hongtao LiuWendy Stock
Dec 20, 2011·Cancer·Anthony R MatoAndre Goy
Jun 22, 2012·Blood·Richard DelarueUNKNOWN Groupe d'Etude des Lymphomes de l'Adulte (GELA)
Apr 16, 2013·Bone Marrow Transplantation·J B CohenK A Blum
May 24, 2013·Leukemia & Lymphoma·Tarunpreet BainsRichard T Maziarz
Jul 23, 2013·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ryan D CassadayAjay K Gopal
Nov 26, 2013·American Journal of Hematology·Julie M Vose
Feb 18, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Ajay K GopalOliver W Press
Apr 2, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eva HosterMichael Unterhalt
May 24, 2014·Leukemia·M DreylingO Hermine
Jul 19, 2014·Leukemia·S RobinsonO Hermine
Jul 22, 2014·Cytometry. Part B, Clinical Cytometry·David WuJonathan R Fromm
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Citations
May 2, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Timothy S FenskeChristopher Bredeson
Sep 30, 2016·Leukemia & Lymphoma·Elisabet E Manasanch
Oct 21, 2016·Cell Biology and Toxicology·Michael P ChuLinda M Pilarski
Mar 14, 2017·Pharmaceuticals·Fengting YanSolomon A Graf
Jun 27, 2017·Cancer Treatment Reviews·Peter MartinMartin Dreyling
Sep 22, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alex F Herrera, Philippe Armand
Aug 12, 2017·Leukemia & Lymphoma·Daniel M GuidotJonathon B Cohen
Feb 28, 2019·Current Hematologic Malignancy Reports·Jennifer Crombie, Philippe Armand
Mar 8, 2019·Expert Review of Hematology·I Brian Greenwell, Jonathon B Cohen
Aug 24, 2017·Current Opinion in Hematology·Umberto Falcone, John Kuruvilla
Mar 15, 2020·American Journal of Hematology·Lawrence D KaplanBruce D Cheson
Oct 13, 2018·Blood Research·Adam M GreenbaumAjay K Gopal
Oct 28, 2017·British Journal of Haematology·Matthew L Chase, Philippe Armand
Jul 12, 2019·Frontiers in Oncology·Sara GalimbertiMario Petrini
Dec 4, 2016·Hematology·Eva Hoster, Christiane Pott
Dec 4, 2016·Hematology·Simon Rule
Jul 15, 2018·Journal of Experimental & Clinical Cancer Research : CR·Haige YeMichael L Wang
Sep 26, 2020·Journal of Hematology & Oncology·Dayoung JungMichael Wang
Aug 31, 2020·Hematology/oncology Clinics of North America·Thomas D Rodgers, Jonathan W Friedberg
Mar 31, 2021·British Journal of Haematology·Elisabeth SilkenstedtMartin Dreyling
Dec 9, 2020·Clinical Lymphoma, Myeloma & Leukemia·Swetha KambhampatiCharalambos B Andreadis
Apr 9, 2021·Annals of Hematology·William H KrügerChristian A Schmidt
May 10, 2021·Transplantation and Cellular Therapy·Farah YassineMohamed A Kharfan-Dabaja
Jun 3, 2021·Cancers·Malte RoerdenJuliane S Walz
Jun 6, 2021·Leukemia Research·Xue WuShan Liu
Jul 14, 2021·Expert Review of Hematology·Andre Goy